HONG KONG – China-based Hansoh Pharmaceutical Group Co. Ltd. had a strong debut on Hong Kong's stock market and raised $1 billion on June 14 – despite widespread protests and a political crisis here – becoming the biggest health care IPO in Hong Kong this year. Read More
HONG KONG – Swedish biopharma Calliditas Therapeutics AB and Singapore-headquartered pharmaceutical company Everest Medicines II Ltd. agreed to develop and commercialize Nefecon for the treatment of IgA nephropathy in greater China and Singapore in a deal valued at more than $121 million. Read More
HONG KONG – The complexity of interactions between the interleukin-17 (IL-17) family of receptors and ligands has been elucidated in a Chinese study, which may lead to development of specific targeting strategies for treating IL-17-related autoimmune inflammatory diseases, notably psoriasis. Read More
The Senate Finance Committee recently met to review the theft of biomedical research funded by taxpayer dollars, but Sen. John Cornyn (R-Texas) said he will shortly issue legislation to address the problem. Cornyn said he may have difficulty voting for funding increases for agencies that do not take such theft seriously, adding that he will soon introduce legislation that would require that the U.S. federal government act to thwart theft from a number of nations, including China, the target of frequent concerns regarding intellectual property theft. Read More
The World Health Assembly, a decision-making body of the World Health Organization (WHO), included a chapter on Chinese traditional medicine in the latest version of its influential global compendium for the first time in history. Read More
Harbour Biomed Therapeutics Ltd., of Shanghai, and Erasmus Medical Center in Rotterdam, the Netherlands, signed a 10-year memorandum of understanding to enable a broad range of joint basic, translational and clinical research activities aimed at developing next-generation biotherapeutics for the treatment of cancer and immunological diseases. Read More
Sumitomo Dainippon Pharma Co. Ltd., of Osaka, Japan, appointed Katsuyuki Kaitonaka to the corporate department of Sumitomo Pharmaceuticals (Suzhou) Co. Ltd., effective July 1, and named Akihisa Fukushima senior fellow, vaccine project, drug research division, effective July 1. Read More
